Olema Pharmaceuticals (OLMA) Other Gross PP&E Adjustments (2020 - 2026)
Olema Pharmaceuticals (OLMA) has 7 years of Other Gross PP&E Adjustments data on record, last reported at -$921000.0 in Q1 2026.
- On a quarterly basis, Other Gross PP&E Adjustments rose 67.57% to -$921000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$921000.0, a 67.57% increase, with the full-year FY2025 number at -$7.4 million, up 10.33% from a year prior.
- Other Gross PP&E Adjustments reached -$921000.0 in Q1 2026 per OLMA's latest filing, up from -$7.4 million in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for OLMA hit a ceiling of -$903000.0 in Q2 2023 and a floor of -$8.3 million in Q4 2024.
- A 5-year average of -$3.4 million and a median of -$2.7 million in 2022 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: crashed 7779.55% in 2022, then surged 67.57% in 2026.
- Tracing OLMA's Other Gross PP&E Adjustments over 5 years: stood at -$5.2 million in 2022, then tumbled by 41.69% to -$7.4 million in 2023, then dropped by 11.91% to -$8.3 million in 2024, then increased by 10.33% to -$7.4 million in 2025, then skyrocketed by 87.59% to -$921000.0 in 2026.
- Business Quant data shows Other Gross PP&E Adjustments for OLMA at -$921000.0 in Q1 2026, -$7.4 million in Q4 2025, and -$1.4 million in Q3 2025.